WELL Health Technologies Corp.

$ 4.17 -4.14 %

WELL Health Technologies Corp. is a leading digital healthcare company with operations in Canada, the United States, and internationally, primarily supporting medical professionals. The company delivers a full spectrum of patient services through various channels. These encompass general primary care; rehabilitative therapies such as physiotherapy, occupational therapy, and chiropractic services; dietary and mental health counselling; and sleep-related treatments. Furthermore, they provide specialized medical attention from gastroenterologists, a wide array of diagnostic services including cardiology, women's health, bone/muscle health, and cancer screening, alongside comprehensive telehealth options. Beyond direct patient care, WELL Health equips practitioners with a suite of technological solutions. This portfolio includes the OSCAR Pro electronic medical record (EMR) system, several virtual health platforms like Tia Health and Circle Medical, and Apps.health, a dedicated marketplace for digital health applications. They also offer Insig for virtual care and patient engagement, revenue cycle management solutions encompassing outsourced billing, and advanced cybersecurity with patient data privacy safeguards. As of December 31, 2021, the company operated 30 primary and executive care clinics, and provided core, specialized, and accredited diagnostic health services from 49 locations throughout Ontario. Established in 2010, the company was initially known as Wellness Lifestyles Inc. before adopting its current name in July 2018. WELL Health Technologies Corp. is headquartered in Vancouver, Canada.

CEO: Hamed Shahbazi - https://www.well.company

Price objectif

-

Recommandation

Hold

DCF

$ 4.46

Loading data...

WELL.TO vs S&P500

Loading data...

No data available.

Quick ratio

0.82

indicates that the company may have difficulty covering its short-term debts with its readily available assets.

P/E ratio

37.91

is considered reasonable, suggesting that the company has a valuation in line with its current profits.

EPS

0.11

is the net profit of a company divided by the number of outstanding shares, indicating the profit earned per share.

ROE

3.15 %

indicates low profitability, suggesting that the company is not using equity efficiently to generate profits.

ROIC

6.43 %

does not generate enough return to cover its financing costs, which indicates value destruction and may pose long-term profitability issues.

WACC

9.99

is a company's average cost of capital, weighted by the proportion of debt and equity in its financing. It represents the minimum return the company must generate to satisfy its investors.

Debt-to-Equity Ratio

0.91

indicates that the company uses more equity than debt, suggesting prudent management.

Free cash flow per share

0.31

is a measure of a company's financial flexibility that is determined by dividing free cash flow by the total number of shares outstanding.

Dividend payout ratio

0.00 %

the dividend payout ratio is the measure of dividends paid out to shareholders relative to the company's net income.

Earnings per share

Loading data...

No data available.

Financials

Piotroski score
5 indicates moderate financial health
Altman score
1.36 indicates a high risk of bankruptcy
Loading data...

No data available.

Cash / Debt

Cash Ratio
0.29 indicates liquidity risk, as the company may not have enough cash to meet its immediate obligations
Debt Ratio
0.37 indicates that the company uses little debt to finance its assets, suggesting good financial stability
Loading data...

No data available.

Free Cash Flow

Loading data...

No data available.

Earnings Per Share (annual)

Loading data...

No data available.

Sales

Loading data...

No data available.